AGP Wins 1st Position in Pharmaceutical Category at BCSR Awards 2024 — for the Second Consecutive Year!

AGP Celebrates Dual Recognition at the 8th Pakistan Pharma Summit & PESA Awards 2025

AGP Receives the 22nd Annual Environment Excellence Award 2025

AGP Wins GDEIB Awards in Nine Categories

AGP x TrashIt Sustainability Training

AGP x Cyber Security Awareness Training

AGP x Cancer Foundation Hospital: Breast Cancer Awareness Session

AGP Visits Karachi Down Syndrome Program (KDSP)

Diwali Celebration at AGP: Honoring Diversity, Culture & Togetherness

AGP Limited Secures 1st Position at BCSR Awards 2023

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Product List

Rigix

Generic:

Cetirizine Dihydrochloride

 

Therapeutic Class:

Antihistamines Systemic

 

Composition:

Each Rigix tablet contains cetirizine dihydrochloride 10 mg.
Each ml of Rigix oral solution contains 1 mg of cetirizine dihydrochloride
 

Description:

Cetirizine, an active metabolite
of hydroxyzine, is an antihistamine; its principal effects are mediated via
selective inhibition of peripheral H1 receptors and are indicated in
allergic conditions

 

Indications:

  • Seasonal allergic rhinitis
  • Perennial allergic rhinitis
  • Chronic idiopathic urticaria
 

Dosage:

Tablets:
Adults & children above 12 years: One 10 mg tablet dailyRigix oral solution can be taken without regard to food consumption.

Children 6 months to <2 years for Perennial Allergic Rhinitis and Chronic Urticaria:

The recommended dose of Rigix oral solution in children 6 months to 23 months of age is 2.5 mg (½ teaspoonful) once daily. The dose in children 12 to 23 months of age can be increased to a maximum dose of 5 mg per day, given as ½ teaspoonful (2.5 mg) every 12 hours.

Children 2 to 5 years for Chronic Urticaria:

The recommended initial dose of Rigix oral solution in children aged 2 to 5 years is 2.5 mg (½ teaspoonful) once daily. The dosage in this age group can be increased to a maximum dose of 5 mg per day given as 1 teaspoonful (5 mg) once daily, or as ½ teaspoonful (2.5 mg) given every 12 hours.

Children 6 years & above:

2 teaspoonfuls once daily or 1 teaspoonful twice daily.

 

 

Presentations:

  • 10 mg tabs 30’s,
  • Oral sol 120ml,